Related Experiment Video
Updated: Jun 15, 2026
08:18
Induction and Validation of Cellular Senescence in Primary Human Cells
Published on: June 20, 2018
p35 is required for CDK5 activation in cellular senescence
1Molecular Oncology Research Institute, Tufts Medical Center, Boston, Massachusetts 02111, USA.
The Journal of Biological Chemistry
|February 26, 2010
Summary
The retinoblastoma protein (pRB) induces cellular senescence via CDK5 kinase. This study shows p35 is essential for pRB-induced CDK5 activation in non-neuronal cells, impacting senescence.
Area of Science:
- Cell Biology
- Molecular Oncology
- Cancer Research
Background:
- The retinoblastoma tumor suppressor gene (RB-1) and its protein (pRB) are crucial regulators of cellular senescence.
- pRB expression in human tumor cells lacking it triggers senescence-like changes.
- pRB-induced senescence relies on CDK5 kinase, typically active in neuronal development.
Purpose of the Study:
- To investigate the role of p35 in CDK5 activation during pRB-mediated cellular senescence in non-neuronal cells.
- To elucidate the mechanism of CDK5 activation in the context of senescence.
Main Methods:
- Expression analysis of p35 in osteosarcoma cells.
- Assessment of p35's requirement for CDK5 activation by pRB during senescence.
- Evaluation of p35's role in senescence-associated morphological changes and secretome expression.
Main Results:
- p35 is expressed in osteosarcoma cells and is required for pRB-induced CDK5 activation.
- p35 is essential for the morphological hallmarks of senescence and the expression of the senescence secretome.
- p35 expression is upregulated in senescing cells.
Conclusions:
- p35 acts as a key activator of CDK5 in the process of cellular senescence.
- These findings offer insights into cancer cell proliferation control.
- The study suggests potential new avenues for cancer therapeutics targeting senescence.
Related Concept Videos
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
02:39Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
01:45Positive Regulator Molecules
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
02:15M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...